Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More


Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... Read More


Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma (RASolute 309)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ve... Read More


Clinical Trial: Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847060) titled 'Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma' ... Read More


Clinical Trial: Impact of Dietary Intervention Within an Interprofessional Cooperative Protocol for Prandial Insulin Dose Adjustment in People Living With Type 1 Diabetes

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846852) titled 'Impact of Dietary Intervention Within an Interprofessional Cooperative Protocol for Prandi... Read More


Clinical Trial: The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846137) titled 'The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum ... Read More


Clinical Trial: Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (FLASH)

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846592) titled 'Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (... Read More


Clinical Trial: Effects of the Buchinger Wilhelmi Fasting Program and Exercise on Physical Fitness and Sleep Quality

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847658) titled 'Effects of the Buchinger Wilhelmi Fasting Program and Exercise on Physical Fitness and Sle... Read More


Clinical Trial: Progressive Heat Exposure and Physiological Strain

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847437) titled 'Progressive Heat Exposure and Physiological Strain' on Sept. 18. Brief Summary: Occupatio... Read More